The FENDRR/FOXC2 Axis Contributes to Multidrug Resistance in Gastric Cancer and Correlates With Poor Prognosis

Hao Liu(National Clinical Research Center for Digestive Diseases), Yongzhan Nie(Xijing Hospital)
Frontiers in Oncology
March 22, 2021
Cited by 19


Related Papers